Management of Chlamydia cases and their partners: Results from a home-based screening program organized by Municipal Public Health Services with referral to regular health care

Sexually Transmitted Diseases

Volumn 32, Issue 10, 2005, Pages 625-629

  Götz, Hannelore M ^a   Hoebe, Christian J P A ^d   Van Bergen, Jan E A M ^b   Veldhuijzen, Irene K ^a   Broer, Jan ^c   De Groot, F ^c   Verhooren, M J C ^e   Van Schaik, D T ^b   Coenen, A J J ^b   Richardus, Jan H ^a,f  

^a Public Health Service of the Rotterdam Region   (Netherlands)

^b National Institute for STI and AIDS Control in the Netherlands   (Netherlands)

^c Municipal Health Service   (Netherlands)

^d Municipal Public Health Service   (Netherlands)

^e Municipal Health Service Hart Voor Brabant   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; DOXYCYCLINE;

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; FEMALE; GENERAL PRACTITIONER; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PATIENT REFERRAL; PUBLIC HEALTH SERVICE; REINFECTION; SCREENING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FAMILY CHARACTERISTICS; FEMALE; HUMANS; LOCAL GOVERNMENT; MALE; MASS SCREENING; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; PUBLIC HEALTH ADMINISTRATION; REFERRAL AND CONSULTATION; SEXUAL PARTNERS;

EID: 26444433229     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000175397.82962.d5     Document Type: Article

References (35)

1. Stamm W. Chlamydia trachomatis. In: Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P, Wasserheit JN (eds.) Sexually Transmitted Diseases. McGraw-Hill, 1999. pp 407-422.
2. Golden MR, Schillinger JA, Markowitz L, St Louis ME. Duration of untreated genital infections with Chlamydia trachomatis: a review of the literature. Sex Transm Dis 2000; 27:329-337.
3. Andersen B, Ostergaard L, Moller JK, Olesen F. Home sampling versus conventional contact tracing for detecting Chlamydia trachomatis infection in male partners of infected women: randomised study. BMJ 1998; 316:350-351.
4. Morre SA, van Valkengoed IG, de Jong A, et al. Mailed, home-obtained urine specimens: a reliable screening approach for detecting asymptomatic Chlamydia trachomatis infections. J Clin Microbiol 1999; 37:976-980.
5. Morre SA, Van Valkengoed IG, Moes RM, Boeke AJ, Meijer CJ, Van den Brule AJ. Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of the LCx and COBAS Amplicor tests with urine specimens. J Clin Microbiol 1999; 37:3092-3096.
6. Martin DH, Mroczkowski TF, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis: the Azithromycin for Chlamydial Infections Study Group. N Engl J Med 1992; 327:921-925.
7. Rietmeijer CA, Van Bemmelen R, Judson FN, Douglas JM Jr. Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening. Sex Transm Dis 2002; 29:65-72.
8. Kretzschmar M. Mathematical epidemiology of Chlamydia trachomatis infections. Neth J Med 2002; 60(7 suppl):35-41.
9. Andersen B, Ostergaard L, Nygard B, Olesen F. Urogenital Chlamydia trachomatis infections in general practice: diagnosis, treatment, follow-up and contact tracing. Fam Pract 1998; 15:223-228.
10. McCree DH, Liddon NC, Hogben M, St Lawrence JS. National survey of doctors' actions following the diagnosis of a bacterial STD. Sex Transm Infect 2003; 79:254-256.
11. Siddiqui F, Kirkman RJ, Chandiok S. Re-audit of referral compliance of chlamydia-positive women from a family planning clinic. J Fam Plann Reprod Health Care 2004; 30:86-87.
12. White C, Wardropper AG. Chlamydia in a district general hospital: an audit of treatment and contact tracing. Int J STD AIDS 1999; 10:57-59.
13. Wilkinson C, Massil H, Evans J. An interface of chlamydia testing by community family planning clinics and referral to hospital genitourinary medicine clinics. Br J Fam Plann 2000; 26:206-209.
14. Willmott F, Tolcher R. Audit of outcome following positive chlamydial test results in family planning clinics in Southampton. Int J STD AIDS 2000; 11:756-758.
15. van Bergen JEAM, Gotz HM, Richardus JH, Hoebe CJPA, Broer J, Coenen AJ. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population-based study in the Netherlands. Sex Transm Infect 2005; 81:17-23.
16. Gotz HM, van Bergen JEAM, Veldhuijzen IK, Broer J, Hoebe CJPA, Richardus JH. A prediction rule for selective screening of Chlamydia trachomatis infection. Sex Transm Infect 2005; 81:24-30.
17. Gotz HM, Veldhuijzen IK, van Bergen JE, Hoebe C, de Zwart O, Richardus JH. Acceptability and consequences of screening for Chlamydia trachomatis by home based urine testing. Sex Trans Dis 2005; 32:557-562.
18. Sexually Transmitted Diseases and Herpes Neonatorum, Guidelines [in Dutch]. Dutch Institute for Healthcare Improvement CBO, 2002.
19. van den Hoek JA, Mulder-Folkerts DK, Coutinho RA, Dukers NH, Buimer M, van Doornum GJ. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population of Amsterdam: over 90% participation and almost 5% prevalence]. Ned Tijdschr Geneeskd 1999; 143:668-672.
20. Pimenta JM, Catchpole M, Rogers PA, et al. Opportunistic screening for genital chlamydial infection, II: prevalence among healthcare attenders, outcome, and evaluation of positive cases. Sex Transm Infect 2003; 79:22-27.
21. van Valkengoed IG, Morre SA, van den Brule AJ, et al. Follow-up, treatment, and reinfection rates among asymptomatic Chlamydia trachomatis cases in general practice. Br J Gen Pract 2002; 52:623-627.
22. Katz BP, Danos CS, Quinn TS, Caine V, Jones RB. Efficiency and cost-effectiveness of field follow-up for patients with Chlamydia trachomatis infection in a sexually transmitted diseases clinic. Sex Transm Dis 1988; 15:11-16.
23. van Valkengoed IG, Morre SA, van den Brule AJ, et al. Partner notification among asymptomatic Chlamydia trachomatis cases, by means of mailed specimens. Br J Gen Pract 2002; 52:652-654.
24. Kissinger P, Brown R, Reed K, et al. Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis. Sex Transm Infect 1998; 74:331-333.
25. Golden MR, Whittington WL, Handsfield HH, et al. Partner management for gonococcal and chlamydial infection: expansion of public health services to the private sector and expedited sex partner treatment through a partnership with commercial pharmacies. Sex Transm Dis 2001; 28:658-665.
26. Klausner JD, Chaw JK. Patient-delivered therapy for chlamydia: putting research into practice. Sex Transm Dis 2003; 30:509-511.
27. Schillinger JA, Kissinger P, Calvet H, et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis 2003; 30:49-56.
28. Dodd A, Comber DL, Hernon M. Chlamydia: inside out. Int J STD AIDS 2002; 13:406-410.
29. Oh MK, Boker JR, Genuardi FJ, Cloud GA, Reynolds J, Hodgens JB. Sexual contact tracing outcome in adolescent chlamydial and gonococcal cervicitis cases. J Adolesc Health 1996; 18:4-9.
30. van de Laar MJ, Termorshuizen F, van den Hoek A. Partner referral by patients with gonorrhea and chlamydial infection: case-finding observations. Sex Transm Dis 1997; 24:334-342.
31. Ostergaard L, Andersen B, Moller JK, Olesen F, Worm AM. Managing partners of people diagnosed with Chlamydia trachomatis: a comparison of two partner testing methods. Sex Transm Infect 2003; 79:358-361.
32. Ashton MR, Cook RL, Wiesenfeld HC, et al. Primary care physician attitudes regarding sexually transmitted diseased. Sex Transm Dis 2002; 29:246-251.
33. Warszawski J, Meyer L. Sex difference in partner notification: results from three population based surveys in France. Sex Transm Infect 2002; 78:45-49.
34. Macke BA, Maher JE. Partner notification in the United States: an evidence-based review. Am J Prev Med 1999; 17:230-242.
35. Mathews C, Coetzee N, Zwarenstein M, et al. A systematic review of strategies for partner notification for sexually transmitted diseases, including HIV/AIDS. Int J STD AIDS 2002; 13:285-300.